Af­ter a slow week, the IPO train is back up and run­ning as 3 more biotechs hop aboard

Af­ter the IPO mar­ket cooled off last week — not just in phar­ma but the en­tire mar­ket, which saw on­ly one pub­lic de­but ac­cord­ing to Re­nais­sance Cap­i­tal — three more biotechs filed their S-1 pa­per­work Fri­day.

The new en­trants are Prometheus Bio­sciences, Long­board Phar­ma­ceu­ti­cals and Gain Ther­a­peu­tics. Prometheus is pen­cil­ing in the high­est raise of the group, es­ti­mat­ing a $125 mil­lion in­flux of cash. Long­board is seek­ing $86 mil­lion, while Gain is look­ing to raise $40 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.